Search bioRxiv⌕ Search

Biology subjects

Clague, M.

Publications and source records attributed to Clague, M..

2 recordsLinked to original sources

Arrested PPTC7 import couples mitochondrial depolarisation to NIX and BNIP3 degradation

Mitophagy is initiated by two distinct pathways that are both coupled to mitochondrial protein import. Import stress stabilises PINK1 at the outer mitochondrial membrane, activating the Parkin and ubiquitin-dependent pathway. Receptor-mediated pathways are governed by the expression of outer mitochondrial membrane proteins NIX and BNIP3. Mitophagy is limited by their degradation, via SCFFBXL4. This requires the PP2C-family phosphatase PPTC7 as an obligate substrate recognition factor, captured at the outer membrane en route to the matrix. We show that mitochondrial depolarisation exerts opposing effects on these two pathways. In RPE1 cells, depolarisation drives rapid, ubiquitin and proteasome-dependent loss of NIX and BNIP3 that requires ongoing protein synthesis of PPTC7. Using a doxycycline-mediated pulse-chase assay, we demonstrate directly that depolarisation inhibits import of newly synthesised PPTC7, and that this arrested PPTC7 is itself degraded in an FBXL4-dependent manner alongside its substrates. Thus, import arrest both stabilises PINK1 and eliminates NIX and BNIP3, coordinating a switch between mitophagy pathways, while concurrent degradation of PPTC7 couples mitophagy receptor turnover to PPTC7 synthesis rates.

cell biology↗

Refined USP25/28 inhibitors with improved selectivity towards c-Myc driven squamous lung cancer cells

The ubiquitin specific protease 28 (USP28) is implicated in tumorigenesis by controlling the turnover of substrates including the oncogene c-MYC and the ubiquitin ligase FBW7. Here, we describe small molecule inhibitors of USP25 and USP28, leading to cancer cell cycle arrest and death. However, genetic deletion of USP25/28 does not replicate this effect. An integrated -omics approach revealed off-target effects for thienopyridine and thienopyrazine carboxamide compounds in protein translation. Chemoproteomics and biochemical analyses suggested binding of such compounds to a region near the ribosome complex polypeptide exit tunnel. Structural analysis of a USP28-inhibitor complex enabled the design of modified USP25/28 inhibitor molecules which minimized translation-related off-target effects. In distinction to earlier compounds, the optimized inhibitors were non-toxic to breast cancer cells yet retained potent anti-proliferative activity in squamous lung carcinoma cells, where USP28 is associated with disease progression. Together, our results demonstrate that refined USP25/28 inhibitors can selectively suppress tumor growth by targeting c-MYC driven pathways, offering a more precise therapeutic strategy for treating squamous lung cancers whilst minimizing undesired cytotoxicity.

cancer biology↗